AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VOLITIONRX LTD Director's Dealing 2014

Sep 29, 2014

34395_dirs_2014-09-29_b9746aca-acdf-4636-b2ac-faccfbdc1469.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2014-09-24

Reporting Person: Colman Alan (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-24	Common Stock	P	3182	$7000	Acquired	53937	Direct

Footnotes

F1: On September 24, 2014, Dr. Alan Colman received 3,182 shares of the Company's common stock with a cost basis of $2.20 per share, as settlement for certain debts owed to Dr. Colman by the Company.